93 related articles for article (PubMed ID: 25665320)
1. [Combined chemotherapy and radiotherapy in bladder cancer: an alternative to surgery?].
Hennequin C; Menard J; Quero L
Rev Prat; 2014 Dec; 64(10):1393-5. PubMed ID: 25665320
[No Abstract] [Full Text] [Related]
2. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit?
Niegisch G; Lorch A; Droller MJ; Lavery HJ; Stensland KD; Albers P
Eur Urol; 2013 Sep; 64(3):355-7. PubMed ID: 23773558
[TBL] [Abstract][Full Text] [Related]
4. Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):7-9. PubMed ID: 12553324
[No Abstract] [Full Text] [Related]
5. Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.
Meijer RP; Meinhardt W; van der Poel HG; van Rhijn BW; Kerst JM; Pos FJ; Horenblas S; Bex A
Int J Urol; 2013 Aug; 20(8):778-84. PubMed ID: 23231456
[TBL] [Abstract][Full Text] [Related]
6. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
7. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
8. [Muscle-invasive bladder cancer].
Pashootan P; Legrand G; Ploussard G
Rev Prat; 2014 Dec; 64(10):1391-2, 1395-8. PubMed ID: 25668831
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.
Wu CE; Lin YC; Hong JH; Chuang CK; Pang ST; Liaw CC
Anticancer Res; 2013 Jun; 33(6):2605-10. PubMed ID: 23749915
[TBL] [Abstract][Full Text] [Related]
11. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
Jakse G; Frommhold H
Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
[No Abstract] [Full Text] [Related]
12. [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions].
Bellefqih S; Khalil J; Mezouri I; ElKacemi H; Kebdani T; Hadadi K; Benjaafar N
Cancer Radiother; 2014 Dec; 18(8):779-89. PubMed ID: 25454383
[TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
Kachnic LA; Shipley WU; Griffin PP; Zietman AL; Kaufman DS; Althausen AF; Heney NM
Cancer J Sci Am; 1996; 2(2):79-84. PubMed ID: 9166504
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
15. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Koukourakis MI; Tsolos C; Touloupidis S
Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
[TBL] [Abstract][Full Text] [Related]
16. Treatment of muscle invasive bladder cancer. Is there a role for neoadjuvant chemotherapy?
Kuten A; Baz M; Rubinov R; Dale J; Haim N; Robinson E; Cohen Y
Strahlenther Onkol; 1994 Sep; 170(9):524-30. PubMed ID: 7524174
[TBL] [Abstract][Full Text] [Related]
17. [FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer].
Ghebriou D; Avenin D; Caillet P; Mongiat-Artus P; Durdux C; Massard C; Culine S
Bull Cancer; 2014 Sep; 101(9):841-55. PubMed ID: 25296412
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in localized bladder cancer: what is the evidence?
Kotwal S; Munro N
Curr Opin Urol; 2010 Sep; 20(5):426-31. PubMed ID: 20657289
[TBL] [Abstract][Full Text] [Related]
19. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
20. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.
Kulkarni GS; Hakenberg OW; Gschwend JE; Thalmann G; Kassouf W; Kamat A; Zlotta A
Eur Urol; 2010 Jan; 57(1):60-70. PubMed ID: 19740595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
